These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 24012959

  • 1. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S, Li Y, Yang Y, Feng D, Yang L, Ma Q, Zheng S, Meng R, Wang S, Wang S, Jiang WG, He J.
    FEBS Lett; 2013 Oct 11; 587(20):3289-95. PubMed ID: 24012959
    [Abstract] [Full Text] [Related]

  • 2. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
    DU G, Hao C, Gu Y, Wang Z, Jiang WG, He J, Cheng S.
    Anticancer Res; 2016 Mar 11; 36(3):1165-73. PubMed ID: 26977012
    [Abstract] [Full Text] [Related]

  • 3. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
    Pan Y, Weinman EJ, Dai JL.
    Breast Cancer Res; 2008 Mar 11; 10(1):R5. PubMed ID: 18190691
    [Abstract] [Full Text] [Related]

  • 4. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.
    Takahashi Y, Morales FC, Kreimann EL, Georgescu MM.
    EMBO J; 2006 Feb 22; 25(4):910-20. PubMed ID: 16456542
    [Abstract] [Full Text] [Related]

  • 5. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
    Zheng J, Dai Y, Yang Z, Yang L, Peng Z, Meng R, Xiong Y, He J.
    Oncol Rep; 2016 Jan 22; 35(1):530-7. PubMed ID: 26531778
    [Abstract] [Full Text] [Related]

  • 6. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
    Pan Y, Wang L, Dai JL.
    Breast Cancer Res; 2006 Jan 22; 8(6):R63. PubMed ID: 17078868
    [Abstract] [Full Text] [Related]

  • 7. NHERF1: molecular brake on the PI3K pathway in breast cancer.
    Georgescu MM.
    Breast Cancer Res; 2008 Jan 22; 10(2):106. PubMed ID: 18430260
    [Abstract] [Full Text] [Related]

  • 8. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
    Saponaro C, Malfettone A, Dell'Endice TS, Brunetti AE, Achimas-Cadariu P, Paradiso A, Mangia A.
    Cancer Biomark; 2014 Jan 22; 14(2-3):177-84. PubMed ID: 24878819
    [Abstract] [Full Text] [Related]

  • 9. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
    Du G, Gu Y, Hao C, Yuan Z, He J, Jiang WG, Cheng S.
    Oncotarget; 2016 May 17; 7(20):29440-53. PubMed ID: 27097111
    [Abstract] [Full Text] [Related]

  • 10. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
    Yang X, Du G, Yu Z, Si Y, Martin TA, He J, Cheng S, Jiang WG.
    Anticancer Res; 2017 Jan 17; 37(1):67-73. PubMed ID: 28011475
    [Abstract] [Full Text] [Related]

  • 11. Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression.
    Yang L, Wang Y, Chen P, Hu J, Xiong Y, Feng D, Liu H, Zhang H, Yang H, He J.
    Endocrinology; 2011 Dec 17; 152(12):4537-49. PubMed ID: 21990315
    [Abstract] [Full Text] [Related]

  • 12. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands.
    Morales FC, Takahashi Y, Momin S, Adams H, Chen X, Georgescu MM.
    Mol Cell Biol; 2007 Apr 17; 27(7):2527-37. PubMed ID: 17242191
    [Abstract] [Full Text] [Related]

  • 13. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
    Meng R, Qin Q, Xiong Y, Wang Y, Zheng J, Zhao Y, Tao T, Wang Q, Liu H, Wang S, Jiang WG, He J.
    Oncotarget; 2016 Aug 23; 7(34):54983-54997. PubMed ID: 27448983
    [Abstract] [Full Text] [Related]

  • 14. NHERF1 regulates gp120-induced internalization and signaling by CCR5, and HIV-1 production.
    Kuang YQ, Pang W, Zheng YT, Dupré DJ.
    Eur J Immunol; 2012 Feb 23; 42(2):299-310. PubMed ID: 22028271
    [Abstract] [Full Text] [Related]

  • 15. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
    Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'Aquila ME, Casavola V, Azzariti A, Mangia A, Paradiso A, Reshkin SJ.
    Mol Biol Cell; 2007 May 23; 18(5):1768-80. PubMed ID: 17332506
    [Abstract] [Full Text] [Related]

  • 16. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.
    Dai JL, Wang L, Sahin AA, Broemeling LD, Schutte M, Pan Y.
    Oncogene; 2004 Nov 11; 23(53):8681-7. PubMed ID: 15467753
    [Abstract] [Full Text] [Related]

  • 17. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.
    Wang JQ, Qin F, Zhu L.
    J Int Med Res; 2015 Oct 11; 43(5):629-38. PubMed ID: 26142394
    [Abstract] [Full Text] [Related]

  • 18. NHERF1 regulates actin cytoskeleton organization through modulation of α-actinin-4 stability.
    Sun L, Zheng J, Wang Q, Song R, Liu H, Meng R, Tao T, Si Y, Jiang W, He J.
    FASEB J; 2016 Feb 11; 30(2):578-89. PubMed ID: 26432781
    [Abstract] [Full Text] [Related]

  • 19. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
    Tao T, Yang X, Qin Q, Shi W, Wang Q, Yang Y, He J.
    Int J Mol Sci; 2017 Jan 12; 18(1):. PubMed ID: 28085111
    [Abstract] [Full Text] [Related]

  • 20. Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour.
    Bellizzi A, Mangia A, Malfettone A, Cardone RA, Simone G, Reshkin SJ, Paradiso A.
    Histopathology; 2011 Jun 12; 58(7):1086-95. PubMed ID: 21707710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.